We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AXDX market cap is 10.91M. The company's latest EPS is USD -4.2949 and P/E is -0.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.96M | 2.97M | 2.81M | 2.92M | 3.3M |
| Operating Income | -14.77M | -14.15M | -16.06M | -12.59M | -14.65M |
| Net Income | -15.71M | -14.8M | -16.8M | -32.74M | 910k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.67M | 9.3M | 11.17M | 11.78M | 12.75M |
| Operating Income | -80.37M | -72.83M | -63.7M | -71.56M | -62.81M |
| Net Income | -88.33M | -84.31M | -78.21M | -77.7M | -62.49M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 75.85M | 65.02M | 51M | 49.88M | 39.32M |
| Total Liabilities | 85.64M | 87.28M | 89.73M | 88.54M | 74.36M |
| Total Equity | -9.8M | -22.26M | -38.73M | -38.66M | -35.03M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 185.27M | 134.42M | 93.43M | 83.05M | 65.02M |
| Total Liabilities | 127.89M | 141.8M | 156.24M | 118.12M | 87.28M |
| Total Equity | 57.38M | -7.38M | -62.81M | -35.07M | -22.26M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.18M | -48.73M | -13.37M | -24.19M | -32.44M |
| Investing | 6.58M | 12.42M | 8.21M | 9.12M | 8.77M |
| Financing | 31.76M | 31.63M | -77k | 9.73M | 8.91M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -67.76M | -64.79M | -50.39M | -47.32M | -48.73M |
| Investing | -20.14M | 52.81M | 13.61M | 8.3M | 12.42M |
| Financing | 125.77M | 6.82M | 11.63M | 43.23M | 31.63M |
| Market Cap | 10.91M |
| Price to Earnings Ratio | -0.17 |
| Price to Sales Ratio | 0.86 |
| Price to Cash Ratio | 0.31 |
| Price to Book Ratio | -0.49 |
| Dividend Yield | - |
| Shares Outstanding | 14.55M |
| Average Volume (1 week) | 59.37k |
| Average Volume (1 Month) | 80.5k |
| 52 Week Change | -89.29% |
| 52 Week High | 11.90 |
| 52 Week Low | 0.73 |
| Spread (Intraday) | 0.02 (2.6%) |
| Company Name | Accelerate Diagnostics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://ir.axdx.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
